Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
In the present study, we investigated two novel mutations of the WASP gene in two Spanish families with patients clinically diagnosed as having XLT and WAS, respectively.
|
17390083 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
The calpain inhibitor calpeptin increased WASP levels in activated T and B cells from the WASP patients, but not in primary T cells from the patients or from WIP(-/-) mice.
|
17213309 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
|
17400488 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Macrophages from WASP-deficient Wiskott-Aldrich syndrome patients lack podosomes, resulting in defective chemotactic migration.
|
17312144 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
|
17400488 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
In the present study, we investigated two novel mutations of the WASP gene in two Spanish families with patients clinically diagnosed as having XLT and WAS, respectively.
|
17390083 |
2007 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia.
|
16804117 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia.
|
16804117 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals.
|
16372137 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
The genotype of the original Wiskott phenotype.
|
17065640 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The patient originally had a single-base deletion (c.11delG; p.G4fsX40) in the WAS (WASP) gene, which resulted in a frameshift and abrogated protein expression.
|
16511828 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder with variable clinical phenotypes that correlate with the type of mutations in the WAS protein (WASP) gene.
|
16630926 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Prenatal diagnosis of the WAS R86H sequence variation in heterozygous twins.
|
16638962 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We investigated retroviral WAS protein (WASP) gene transfer to assess functional correction and potential toxicities in human CD34(+) cells from WAS patients and healthy individuals, respectively.
|
16939809 |
2006 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The Wiskott-Aldrich syndrome protein (WASp) is mutated in the severe immunodeficiency disease Wiskott-Aldrich syndrome (WAS).
|
15383456 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
LHGDN |
NMR analyses of the activation of the Arp2/3 complex by neuronal Wiskott-Aldrich syndrome protein.
|
16285728 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Genotype-proteotype linkage in the Wiskott-Aldrich syndrome.
|
16002738 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency/platelet disease due to mutations of WASP, a cytoskeletal regulatory protein of blood cells.
|
15654828 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Wiskott-Aldrich syndrome (WAS) is an immune deficiency with thrombopenia resulting from mutations in the WASP gene.
|
15616597 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome.
|
16091449 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
LHGDN |
The nucleotide switch in Cdc42 modulates coupling between the GTPase-binding and allosteric equilibria of Wiskott-Aldrich syndrome protein.
|
15821030 |
2005 |
Wiskott-Aldrich Syndrome
|
1.000 |
AlteredExpression
|
disease |
LHGDN |
Mutations of the Wiskott-Aldrich syndrome protein (WASP) gene result either in the classic Wiskott-Aldrich syndrome (WAS) or in a less severe form, X-linked thrombocytopenia (XLT).
|
12969986 |
2004 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Identification of WASP mutations in 10 unrelated Australian families presenting with clinical features of WAS/XLT.
|
15203732 |
2004 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by eczema, thrombocytopenia and increased susceptibility of infections, with mutations of the WAS gene being responsible for WAS and X-linked thrombocytopenia.
|
15469902 |
2004 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.
|
15284122 |
2004 |